In this study, we aimed to investigate the differences in clinicopathological characteristics and survival outcomes between patients with HER2-low breast cancer and those with HER2-IHC 0 breast cancer using nationwide data from the Korean Breast Cancer Registry (KBCR). Here, ERBB2 is linked to breast cancer.